Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers E > Headlines for Elite Pharmaceuticals Inc. > News item |
Elite chairman converts $1 million 10% credit line to convertibles
Interest-free unsecured convertible notes will be due in November 2016
By Devika Patel
Knoxville, Tenn., Nov. 26 - Elite Pharmaceuticals Inc. said its chairman of the board, Jerry Treppel, has chosen to convert the principal of his $1 million credit line into an unsecured convertible note.
The credit line accrues interest at 10% and is due on July 31, 2014. The remaining $600,000 of principal under the credit line has now been converted to an interest-free, convertible note, which matures in November 2016.
Based in Northvale, N.J., Elite develops oral controlled-release products.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.